BIOMAT Database Logo BIOMAT Database Logo

Reactogenicity and immunogenicity of oral cholera vaccine in Thai volunteers. 1988

S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

UI MeSH Term Description Entries
D007071 Immunoglobulin A, Secretory The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS). Colostral IgA,IgA, Exocrine,IgA, Secretory,SIgA,Secretory IgA,Secretory Immunoglobulin A,Exocrine IgA,IgA, Colostral
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007419 Intestinal Secretions Fluids originating from the epithelial lining of the intestines, adjoining exocrine glands and from organs such as the liver, which empty into the cavity of the intestines. Intestinal Secretion,Secretion, Intestinal,Secretions, Intestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D013785 Thailand Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city. Kingdom of Thailand,Siam
D014734 Vibrio cholerae The etiologic agent of CHOLERA. Bacillus cholerae,Bacillus cholerae-asiaticae,Liquidivibrio cholerae,Microspira comma,Pacinia cholerae-asiaticae,Spirillum cholerae,Spirillum cholerae-asiaticae,Vibrio albensis,Vibrio cholera,Vibrio cholerae-asiaticae,Vibrio comma
D015164 Vaccines, Inactivated Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. Inactivated Vaccine,Killed Vaccine,Killed Vaccines,Vaccines, Killed,Inactivated Vaccines,Vaccine, Inactivated,Vaccine, Killed

Related Publications

S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Immunogenicity of two formulations of oral cholera vaccines in Thai volunteers.
January 1991, Vaccine,
S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers.
April 1998, Vaccine,
S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers.
July 1999, The Pediatric infectious disease journal,
S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Symptoms of reactogenicity in field trial of oral cholera vaccine.
August 1990, Lancet (London, England),
S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Immunogenicity and reactogenicity of a yeast-derived hepatitis B vaccine in Thai school children.
January 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity.
October 1989, The Pediatric infectious disease journal,
S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial.
March 2019, Vaccine,
S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.
January 1992, Vaccine,
S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers.
June 1993, The Journal of infectious diseases,
S Migasena, and P Pitisuttitham, and W Supanaranond, and V Desakorn, and B Prayurahong, and P Suntharasamai
Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases.
May 2022, Vaccines,
Copied contents to your clipboard!